News

Colourful kites fill the skies as participants from around the world gather in Sri Lanka's capital for the Colombo International Kite Festival. More than 55 international kite flyers representing 25 ...
Kite has entered into a definitive agreement to acquire Interius BioTherapeutics, a privately held company developing in vivo CAR therapeutics.
Gilead subsidiary Kite Pharma said that it has acquired Interius BioTherapeutics and its single-shot CAR-T program for $350 million.
A free two-day event coming to scenic rural Ontario is melding classic festival offerings like food, vendors and live music ...
Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy ...
Colombo's Galle Face Green park was transformed into a spectacle of color on Sunday (August 24) as thousands of kite enthusiasts gathered for the city's International Kite festival.
All arrangements are in place for the Derana Signal Colombo International Kite Festival 2025, which will take place today (24 ...
Kite, a Gilead Company, has agreed to acquire Interius BioTherapeutics, a privately held biotechnology company developing in vivo CAR therapeutics.
Some King Park residents say the site cleanup activity is obstructing the area's silence and the view of Lake Michigan.